Congenital myopathies – skeletal muscle diseases related to disorder of actin filament structure and functions
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2011, Vol 65, Issue 0
Abstract
Congenital myopathies are clinically and genetically heterogeneous disorders characterized by muscle structural abnormalities, muscle weakness and deformities. The clinical spectrum of the disease ranges from severe cases with early death to adult-onset cases with slow progression. In the skeletal muscle fibers, the specific structural changes are rod-shaped structures present in the sarcoplasm (nemaline myopathy – NM) or nuclei (intranuclear rod myopathy – IRM), cap-like structures peripherally located within muscle fibers (cap disease – CD), accumulations of actin filaments (actin myopathy – AM), changes in the fiber type proportion and size (congenital fiber type disproportion – CFTD), irregularity of Z-lines and abnormal localization of myofiber nuclei. Mutations in several genes encoding muscle proteins have been linked to congenital myopathy. These genes include -skeletal actin ([i]ACTA1[/i]), tropomyosin ([i]TPM2[/i] and [i]TPM3[/i]), troponin ([i]TNNT1[/i]) and nebulin ([i]NEB[/i]). [i]In vitro[/i] and [i]in vivo[/i] studies show that mutations identified within these genes have varying impacts on thin filament protein structure, which affect polymerization and stabilization of actin filament, actin cellular localization and regulation of actin-myosin activity. Many lines of evidence suggest that mutated proteins have “toxic” effects. Unfortunately, there is no existing simple correlation between the degree of protein disruption, muscle pathologies and disease severity.
Authors and Affiliations
Katarzyna Robaszkiewicz, Joanna Moraczewska
Keywords
Related Articles
- EP ID EP66486
- DOI -
- Views 168
- Downloads 0
Rola wapnia i kalmoduliny w reakcji skurczu dna żołądka
Wstęp: Przedmiotem pracy jest określenie wpływu kalmoduliny oraz wapnia na skurcz mięśniówki gładkiej dna żołądka. W przeprowadzonych doświadczeniach badano wpływ agonisty receptorów serotoninowych – serotoniny (5-HT), w...
The role of ghrelin in the organism
Ghrelin was discovered in 1999 as an endogenous ligand of the growth hormone secretagogue receptor (GHS-R). About 60–70% of ghrelin in the blood is released from oxyntic cells (X/A-like cells) of the stomach body and f...
Stężenie karnityny w surowicy jest obniżone u pacjentów chorych na boreliozę z Lyme
Hemoglobin adducts as biomarkers of human exposure to selected xenobiotics
In the living and working environments more and more new substances of anthropogenic origin exerting toxic properties appear. Simultaneously, the evaluation of human exposure is assessed. For many years adducts of hemogl...
Research on new drugs in the therapy of bladder cancer (BC)
New, more effective and safer therapies in bladder cancer are being developed. Most attention is focused on monoclonal antibody therapies, targeted therapies and immunotherapy. Numerous pre-clinical and clinical studies...